Back to Search
Start Over
Viable SARS-CoV-2 shedding under remdesivir and dexamethasone treatment.
- Source :
- Journal of Infection; Jun2022, Vol. 84 Issue 6, p834-872, 39p
- Publication Year :
- 2022
-
Abstract
- • The cycle threshold (Ct) value of RT-PCR was not significantly reduced by remdesivir. • Infectious virus was not detected after the third dose of remdesivir despite dexamethasone treatment. • SARS-CoV-2 shedding significantly decreased after remdesivir treatment, regardless of the Ct value. • Rapid antigen test is a viable adjunctive tool that guides the decision to terminate the isolation. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 01634453
- Volume :
- 84
- Issue :
- 6
- Database :
- Supplemental Index
- Journal :
- Journal of Infection
- Publication Type :
- Academic Journal
- Accession number :
- 157000008
- Full Text :
- https://doi.org/10.1016/j.jinf.2022.03.022